Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer | Journal of Clinical Oncology
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | The Patient - Patient-Centered Outcomes Research
Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for. - ppt download
Progression-Free Survival: Meaningful or Simply Measurable? | Journal of Clinical Oncology
Extrapolation from Progression Free Survival to Overall Survival in Oncology | PPT
PPT - Overall Survival and Progression-Free Survival PowerPoint Presentation - ID:4064400
Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting | Radiation Oncology | Full Text
Cancers | Free Full-Text | Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Progression-free survival (A) and overall survival (B) | Open-i
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Progression-free survival (A) and overall survival of ( | Open-i
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram
Overall survival vs disease-free survival and other surrogate endpoints - survival-analysis - Datamethods Discussion Forum
Progression-free survival (PFS), event-free survival (EFS), and overall... | Download Scientific Diagram
Real-World Progression-Free Survival as an Endpoint in Advanced Non-Small-Cell Lung Cancer: Replicating Atezolizumab and Docetaxel Arms of the OAK Trial Using Data Derived From Electronic Health Records | medRxiv
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma | NEJM
Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting | Radiation Oncology | Full Text
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
Progression-free survival and overall survival curves for all patients... | Download Scientific Diagram
![PDF] Outcomes and endpoints in trials of cancer treatment: the past, present, and future. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/226a8780e04804a8a77db2a45c03766c3e65bf27/3-Figure1-1.png "PDF] Outcomes and endpoints in trials of cancer treatment: the past, present, and future. | Semantic Scholar")
PDF] Outcomes and endpoints in trials of cancer treatment: the past, present, and future. | Semantic Scholar
